Latest Biomass News

New Zealand King Salmon reported an FY25 net loss driven by a shortened reporting period and biological challenges, while advancing its Blue Endeavour pilot project despite delays. The company projects a cautious recovery in FY26 with EBITDA guidance between NZD 9 million and 15 million.

New Zealand King Salmon reports a $6.3 million net loss for an eight-month FY25 period, reflecting operational challenges and a shortened reporting cycle, while outlining cautious optimism for FY26 with targeted growth investments.

Genesis Energy’s 2025 Investor Day confirms its strategy and earnings growth remain firmly on track, anchored by a substantial renewable pipeline and robust capital management.

Bio-Gene Technology reports significant progress in developing its bio-insecticides Flavocide and Qcide, including new efficacy data and organic certification, positioning the company for growth amid rising global demand for safer pest control.

Bio-Gene Technology Limited reports significant progress in Q1 FY26, unveiling new product opportunities and positive efficacy data, alongside securing US Department of Defense grants.

Gold Hydrogen Limited has closed a $14.5 million strategic investment round led by Toyota, Mitsubishi Gas Chemical, and ENEOS Xplora, positioning the company to accelerate drilling and commercialisation efforts at its Ramsay Project in South Australia.

Murray Cod Australia Ltd reports a robust start to FY26 with a 45% increase in sales and a $17 million capital raise, driven by expanded production and market access including new Halal certification.

Genesis Energy reported a robust start to FY26, boosted by strong hydro generation and strategic digital investments, setting a positive tone for the year ahead.

Murray Cod Australia Limited reports a profitable FY25 with a significant biomass increase and completes a $17 million capital raise to fund infrastructure and market expansion ahead of a commercial inflection in FY26.

New Zealand King Salmon reported a $20.8 million net loss for the half year ending July 2025, driven by biological setbacks and reduced harvests. Despite this, the company maintains a strong balance sheet and is advancing its Blue Endeavour pilot farm and growth initiatives.

New Zealand King Salmon Investments Limited reported a significant interim loss driven by biological asset valuation pressures and operational costs, while announcing a strategic $8.14 million property purchase.

New Zealand King Salmon reports a $20.8 million net loss for the half-year ending July 2025, driven by biological asset write-downs, while maintaining EBITDA guidance and advancing key growth initiatives.